• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Inspire Medical Systems Inc (NY: INSP )

    214.93 +9.93 (+4.84%)
    Official Closing Price Updated: 4:10 PM EDT, Oct 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 417,210
    Open 207.01
    Bid (Size) 213.99 (1)
    Ask (Size) 219.00 (1)
    Prev. Close 205.00
    Today's Range 205.24 - 214.97
    52wk Range 123.00 - 257.40
    Shares Outstanding 27,271,598
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Analyst Scoreboard: 7 Ratings For Inspire Medical Systems
    Via Benzinga
    The Analyst Verdict: Inspire Medical Systems In The Eyes Of 7 Experts
    Via Benzinga

    Performance

    YTD
    +14.42%
    +14.42%
    1 Month
    +9.10%
    +9.10%
    3 Month
    +52.57%
    +52.57%
    6 Month
    -3.58%
    -3.58%
    1 Year
    +21.34%
    +21.34%

    More News

    Read More
    Terns Pharmaceuticals, Boeing, Tesla And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Shopify Posts Upbeat Earnings, Joins Axon Enterprise, Aspen Technology, Illumina, Global Payments And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Deep Dive Into Inspire Medical Systems Stock: Analyst Perspectives (6 Ratings)
    Via Benzinga
    What Analysts Are Saying About Inspire Medical Systems Stock
    Via Benzinga
    Expert Ratings For Inspire Medical Systems
    Via Benzinga
    INSP Stock Earnings: Inspire Medical Systems Beats EPS, Beats Revenue for Q2 2024
    Via InvestorPlace
    INSPIRE MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Inspire Medical Systems, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    FDA Labels Inspire Medical's Sleep Apnea Nerve Stimulator Recall As Most Serious
    Via Benzinga
    Topics Product Recall
    Exposures Legal Product Safety
    Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
    Via MarketBeat
    Exposures Product Safety
    ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday
    Via Benzinga
    Eli Lilly's Weight-Loss Drug Takes Down ResMed, Inspire Medical — Again
    Via Investor's Business Daily
    Jim Cramer: Celestica Makes A 'Comeback,' Sell This Movie Theater Stock,
    Via Benzinga
    7 Undervalued Stocks That Could Triple Your Money by 2026
    Via InvestorPlace
    Dow Gains 150 Points; Emerson Electric Earnings Top Views
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Crude Oil Moves Higher; Inspire Medical Systems Shares Plummet
    Via Benzinga
    Exposures Fossil Fuels
    Why RingCentral Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Flywire Reports Q1 Loss, Joins ZoomInfo, Inspire Medical Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    INSP Stock Earnings: Inspire Medical Systems Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.